Ignite Creation Date:
2024-05-06 @ 1:41 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04097561
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2019-09-19
Brief Title:
Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies Phoebe
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-29
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-19
First Submit QC Date:
September 19 2019
Study First Post Date:
2019-09-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-02
Last Update Post Date:
2024-06-25
Last Update Post Date Type:
ACTUAL